Ginsenoside Rh2

人参皂苷Rh2

Report date: 2022/01/20 13:30:18

Base Information

Drug NameGinsenoside Rh2
Drug Alias Name20(S)-Ginsenoside Rh220(S)-人参皂苷Rh23-O-beta-D-Glucopyran osyl-20(S)- protopanaxadiolRh2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent deacetylase sirtuin 1 stimulantsCaspase stimulants
TargetsNAD-dependent deacetylase sirtuin 1Caspase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesShanghai Pharm Valley Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Pharm Valley Corp
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A